CUSIP: 03152W109
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
316,644,581
-
Total 13F shares
-
292,444,452
-
Share change
-
-362,784
-
Total reported value
-
$3,570,548,028
-
Put/Call ratio
-
78%
-
Price per share
-
$12.21
-
Number of holders
-
225
-
Value change
-
+$6,804,421
-
Number of buys
-
123
-
Number of sells
-
96
Security key
03152W109
Report period
Q4 2022
Institutions
225
Top holders
10
Reporting periods
Holder history for CUSIP 03152W109
Recent filing periods:
Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2022
As of 31 Dec 2022,
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by
225 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
292,444,452 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., MORGAN STANLEY, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, STATE STREET CORP, and Palo Alto Investors LP.
This page lists
225
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2022 vs Q3 2022 Across Filers
| Investor |
Q3 2022 Shares |
Q4 2022 Shares |
Share Diff |
Share Chg % |
Q3 2022 Value $ |
Q4 2022 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.